mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.0008 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |